Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Novartis
Chubb
UBS
Boehringer Ingelheim
Federal Trade Commission
McKesson
Cantor Fitzgerald
Farmers Insurance
Covington

Generated: August 20, 2017

DrugPatentWatch Database Preview

MEPERIDINE AND ATROPINE SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Meperidine And Atropine Sulfate, and when can generic versions of Meperidine And Atropine Sulfate launch?

Meperidine And Atropine Sulfate is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in MEPERIDINE AND ATROPINE SULFATE is atropine sulfate; meperidine hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.

Summary for Tradename: MEPERIDINE AND ATROPINE SULFATE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list105,776
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEPERIDINE AND ATROPINE SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
MEPERIDINE AND ATROPINE SULFATE
atropine sulfate; meperidine hydrochloride
INJECTABLE;INJECTION085121-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
MEPERIDINE AND ATROPINE SULFATE
atropine sulfate; meperidine hydrochloride
INJECTABLE;INJECTION085121-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
MEPERIDINE AND ATROPINE SULFATE
atropine sulfate; meperidine hydrochloride
INJECTABLE;INJECTION085121-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Argus Health
Fish and Richardson
US Department of Justice
US Army
McKesson
Mallinckrodt
Cipla
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot